Atlas Trials

Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8

RecordFirmDate
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab (NCT07003100)City of Hope Medical Center2024-12-06
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma (NCT04930653)City of Hope Medical Center2022-10-19
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment (NCT04541017)National Cancer Institute (NCI)2021-04-06
Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides (NCT03695471)Mayo Clinic2020-02-04

Track Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.